Pharmos Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2007
2008
2009
2010
2011
Cost of Goods Sold (COGS) incl. D&A
-
-
-
1.60
-
Gross Income
-
-
-
1.60
-
SG&A Expense
17,344.10
10,993.90
5,959.10
1,440.80
1,876.10
EBIT
17,579.30
11,100.20
5,967.40
1,442.30
1,878.90
Unusual Expense
-
51.10
776.10
-
-
Non Operating Income/Expense
59.30
92.50
8.40
5.80
2.40
Interest Expense
-
490.50
225.30
110.70
102.80
Pretax Income
16,581.60
11,293.50
6,968.80
1,545.70
1,979.00
Income Tax
955.80
1,204.10
3,914.50
-
-
Consolidated Net Income
15,625.80
10,089.40
3,054.30
1,545.70
1,979.00
Net Income
15,625.80
10,089.40
3,054.30
1,545.70
1,979.00
Net Income After Extraordinaries
15,625.80
10,089.40
3,054.30
1,545.70
1,979.00
Net Income Available to Common
15,625.80
10,089.40
3,054.30
1,545.70
1,979.00
EPS (Basic)
0.61
0.39
0.06
0.03
0.03
Basic Shares Outstanding
25,591.70
25,935.00
47,445.00
58,529.20
59,195.40
EPS (Diluted)
0.61
0.39
0.06
0.03
0.03
Diluted Shares Outstanding
25,591.70
25,935.00
47,445.00
58,529.20
59,195.40
EBITDA
17,344.10
10,993.90
5,959.10
1,440.80
1,876.10
Non-Operating Interest Income
938.30
255.80
8.40
1.50
0.30
About Pharmos
View Profile
